Nyxoah SA
XBRU:NYXH
Nyxoah SA
XBRU:NYXH
Price:
3.235
EUR
-5.13%
Market Cap:
€139.2m
Relative Value
The Relative Value of one
NYXH
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 3.235 EUR,
Nyxoah SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NYXH Relative Value
HIDDEN
Multiples Across Competitors
NYXH Competitors Multiples
Nyxoah SA Competitors
Nyxoah SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BE |
|
Nyxoah SA
XBRU:NYXH
|
143.3m EUR | 24.7 | -1.7 | -1.9 | -1.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192.4B USD | 4.3 | 29.5 | 16.9 | 23.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.6B USD | 17.4 | 61.5 | 46.7 | 57.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
141.6B USD | 5.6 | 43.6 | 22.1 | 26.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
119.3B USD | 3.4 | 25.9 | 14.1 | 20.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.7B USD | 5.3 | 37 | 21.7 | 29.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46B EUR | 2 | 21.6 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
49.3B USD | 11.5 | 46.6 | 33.1 | 36.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD | 8 | 45.2 | 24.9 | 27.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
47.9B USD | 2.2 | 27.3 | 10.6 | 17.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.9B USD | 6.9 | 24.9 | 17.6 | 19.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
